Levothyroxine: clinically important differences between products Media release 21 January 2013 Pages: 2 - 2
Viruses increase alemtuzumab neurological complication risk? Clinical study 21 January 2013 Pages: 2 - 2
Tamoxifen reverses antineoplastic-associated lipid disorders? Clinical study 21 January 2013 Pages: 3 - 3
Docetaxel-induced hypersensitivity reactions of a nonallergic nature Clinical study 21 January 2013 Pages: 4 - 4
Further evidence of an association between leflunomide and neuropathy Incidence study 21 January 2013 Pages: 4 - 4
PI therapy: risk of lipid disorders elevated during puberty? Incidence study 21 January 2013 Pages: 4 - 4
Fluvastatin/pravastatin: no significant impact on plasma indinavir Clinical study 21 January 2013 Pages: 5 - 5
Irinotecan-induced toxicity: polymorphisms and prophylaxis Clinical study 21 January 2013 Pages: 5 - 5